2011
DOI: 10.1016/j.biomaterials.2011.01.047
|View full text |Cite
|
Sign up to set email alerts
|

A perfluoropolyether corneal inlay for the correction of refractive error

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2011
2011
2015
2015

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 33 publications
0
7
0
Order By: Relevance
“…Current presbyopic treatment options for these patients include monocular implantation of a presbyopic intrastromal inlay, such as the Kamra (AcuFocus, Irvine, CA) or PresbyLens (ReVision Optics, Lake Forest, CA), both of which are currently undergoing U.S. Food and Drug Administration clinical trials; Laser Blended Vision (Carl Zeiss Meditec); and refractive lens exchange. However, biocompatibility related complications of non-biological implants have been reported in the literature, which included alterations in tear film thickness and corneal topography [45], corneal erosions [46], and peri-inlay deposits [47]. Corneal stromal restoration through RL re-implantation presents the opportunity for restoring the myopic status in the non-dominant eye to previous low myopia, thus resulting in monovision [48].…”
Section: Discussionmentioning
confidence: 99%
“…Current presbyopic treatment options for these patients include monocular implantation of a presbyopic intrastromal inlay, such as the Kamra (AcuFocus, Irvine, CA) or PresbyLens (ReVision Optics, Lake Forest, CA), both of which are currently undergoing U.S. Food and Drug Administration clinical trials; Laser Blended Vision (Carl Zeiss Meditec); and refractive lens exchange. However, biocompatibility related complications of non-biological implants have been reported in the literature, which included alterations in tear film thickness and corneal topography [45], corneal erosions [46], and peri-inlay deposits [47]. Corneal stromal restoration through RL re-implantation presents the opportunity for restoring the myopic status in the non-dominant eye to previous low myopia, thus resulting in monovision [48].…”
Section: Discussionmentioning
confidence: 99%
“…The bundles enter the cornea at the periphery in a radial fashion parallel to the corneal surface exerting important trophic influences on the corneal epithelium and contributing to the maintenance of a healthy ocular surface [25]. Although LASIK is the commonest technique reported to aid inlay implantation [26, 27] there is complete transection of the sub-epithelial corneal nerves that may require 6 months to several years to heal [28] and the creation of a cornea flap causes permanent stromal damage because it never fully heals. For these reasons creating a deep corneal stromal pocket will cause less nerve damage than a flap and for this study we therefore adopted a surgical technique that allowed us to selectively evaluate the inlays in non-neurotrophic corneal tissue.…”
Section: Discussionmentioning
confidence: 99%
“…With the inevitable development of presbyopia, refractive laser treatments, such as monovision LASIK [ 22 ] and presbyLASIK [ 25 ] are possible following re-implantation. Although monocular implantation of a presbyopic intrastromal inlay, such as the Kamra (AcuFocus, Irvine, CA) or PresbyLens (ReVision Optics, Lake Forest, CA), could be a viable option for this group of patients without re-implantation, biocompatibility related complications can potentially arise from using non-biological implants, which include alterations in tear film thickness and corneal topography [ 26 ], corneal erosions [ 27 ], and peri-inlay deposits [ 28 ].…”
Section: Discussionmentioning
confidence: 99%